Atrys Health, S.A. (BME:ATRY)
Spain
· Delayed Price · Currency is EUR 3.000
-0.020 (-0.66%)
Mar 31, 2025, 2:41 PM CET
Atrys Health Revenue
In the year 2024, Atrys Health had annual revenue of 224.98M EUR with 9.16% growth. Atrys Health had revenue of 109.36M in the half year ending June 30, 2024, with 20.84% growth.
Revenue
224.98M
Revenue Growth
+8.69%
P/S Ratio
1.02
Revenue / Employee
107.95K
Employees
2,061
Market Cap
229.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.98M | 18.88M | 9.16% |
| Dec 31, 2023 | 206.10M | 42.90M | 26.28% |
| Dec 31, 2022 | 163.20M | 39.35M | 31.77% |
| Dec 31, 2021 | 123.85M | 90.04M | 266.34% |
| Dec 31, 2020 | 33.81M | 17.15M | 102.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.21B |
| Laboratorios Farmaceuticos Rovi | 763.75M |
| Almirall | 990.63M |
| Pharma Mar | 174.86M |
| Faes Farma | 510.04M |
| Clínica Baviera | 265.72M |
| Oryzon Genomics | 7.36M |
| Laboratorio Reig Jofre | 338.90M |